Danaher and Microsoft Build Agentic AI Platform for Life Sciences Laboratories
Danaher and Microsoft announced a collaboration to connect scientific instruments through an agentic AI platform on Azure and Foundry, with first commercial applications expected later this year.

By Clara Tan, Artificial Intelligence
4 min read
What changed
Danaher Corporation (NYSE: DHR) and Microsoft announced on 20 November 2026 a collaboration to build a common agentic AI platform for life sciences laboratories. The partnership combines Danaher's scientific instrumentation portfolio with Microsoft's Azure cloud and Foundry AI agent framework to connect laboratory instruments so they can share context, interpret experimental data and continuously inform the next experiment.
What the platform can do
Connecting instruments across the lab
The platform creates a "common foundation" so that Danaher instruments spanning life sciences, diagnostics and bioprocessing work together consistently as one connected system. Instead of each instrument generating isolated data files, the agentic layer interprets experimental results in context and can suggest the next analytical step.
Agentic interpretation of experimental data
Using Microsoft Foundry, AI agents can read instrument outputs, compare them against historical runs and propose adjustments. For example, a bioreactor run that shows unexpected metabolite profiles could trigger the agent to recommend specific analytical assays on connected instruments, then feed those results back into the next bioreactor run design.
Continuous learning across experiments
Julie Sawyer Montgomery, Danaher Executive Vice President, said: "With Microsoft, we are building a common foundation, so our instruments and laboratories work together consistently, as one connected Danaher. Through context and learning, that foundation can continuously inform the next experiment and the best analysis."
Jason Zander, Microsoft Executive Vice President for Strategic Missions and Technologies, added that the partnership applies "Microsoft's AI platform and cloud to Danaher's deep scientific and instrumentation expertise" to accelerate scientific discovery.
Where it has gone wrong or the limits
The announcement does not specify which Danaher operating companies or instrument lines will be connected first.
No technical details on the agent architecture, data schemas or interoperability standards were disclosed.
No pricing, licensing or rollout timeline beyond "later this year" for first commercial applications.
The agentic platform is described as a development effort; no customer deployments or benchmarks are cited.
Why it matters
Life sciences laboratories generate massive instrument data that often remains siloed. An agentic layer that connects instruments, interprets results and proposes next experiments could reduce cycle times for drug discovery, diagnostics development and bioprocessing optimisation. Danaher's breadth across the lab workflow (from sample prep to analytics to bioproduction) gives the partnership a unique surface area for integration.
Background
Date | Event |
|---|---|
20 Nov 2026 | Danaher and Microsoft announce life sciences AI alliance |
2025-2026 | Microsoft Foundry launches as AI agent framework on Azure |
2023-2025 | Danaher acquires multiple life sciences instrumentation companies |
What to watch
Which Danaher operating companies (Cytiva, Pall, Beckman Coulter, Leica, SCIEX, etc.) ship first connected instruments.
Whether the platform adopts open standards (e.g., SiLA, AnIML) or remains proprietary.
Customer pilot results and any published benchmarks on experiment cycle-time reduction.
Microsoft's broader Foundry adoption in other scientific domains.
This story was first published by TechWhoKnows on 22 November 2026. Original: https://techwhoknows.com/tech/danaher-and-microsoft-build-agentic-ai-platform-for-life-sciences-laboratories
Sources
- 1Danaher Investor Relations press releaseinvestors.danaher.com